Suppr超能文献

开发一个半机械药代动力学-药效学模型,描述单剂量右旋苯丙胺给药后大鼠和非人灵长类动物的右旋苯丙胺暴露和纹状体多巴胺反应。

Development of a Semimechanistic Pharmacokinetic-Pharmacodynamic Model Describing Dextroamphetamine Exposure and Striatal Dopamine Response in Rats and Nonhuman Primates following a Single Dose of Dextroamphetamine.

机构信息

Charles River Laboratories Germany GmbH, Göttingen, Germany (M.M.v.G., C.S.); Charles River Laboratories Den Bosch BV, 's-Hertogenbosch, The Netherlands (J.F.); Duquesne School of Pharmacy and Graduate School of Pharmaceutical Sciences, Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University, Pittsburgh, Pennsylvania (S.A., C.B., D.S., R.E.S.).

Charles River Laboratories Germany GmbH, Göttingen, Germany (M.M.v.G., C.S.); Charles River Laboratories Den Bosch BV, 's-Hertogenbosch, The Netherlands (J.F.); Duquesne School of Pharmacy and Graduate School of Pharmaceutical Sciences, Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University, Pittsburgh, Pennsylvania (S.A., C.B., D.S., R.E.S.)

出版信息

J Pharmacol Exp Ther. 2019 Apr;369(1):107-120. doi: 10.1124/jpet.118.254508. Epub 2019 Feb 7.

Abstract

Acute central nervous system exposure to dextroamphetamine (d-amphetamine) elicits a multitude of effects, including dual action on the dopamine transporter (DAT) to increase extracellular dopamine, and induction of a negative feedback response to limit the dopamine increase. A semimechanistic pharmacokinetic and pharmacodynamic (PK/PD) model with consideration of these multiple effects as a basis was developed. Integrated pharmacokinetics of d-amphetamine in plasma, brain extracellular fluid (ECF) via microdialysis, and cerebrospinal fluid were characterized using a population approach. This PK model was then linked to an indirect-response pharmacodynamic model using as a basis the measurement of extracellular striatal dopamine, also via microdialysis. In both rats and nonhuman primates (NHPs), d-amphetamine stimulation of dopamine outflow (reverse transport) through DAT was primarily responsible for the dose-linear increase in dopamine. As well, in both species a moderator function was needed to account for loss of the dopamine response in the presence of a relatively sustained d-amphetamine ECF exposure, presumptive of an acute tolerance response. PK/PD model structure was consistent between species; however, there was a 10-fold faster return to baseline dopamine in NHPs in response to an acute d-amphetamine challenge. These results suggest preservation from rodents to NHPs regarding the mechanism by which amphetamine increases extracellular dopamine, but a faster system response in NHPs to tolerate this increase. This microdialysis-based PK/PD model suggests greater value in directing preclinical discovery of novel approaches that modify reverse transport stimulation to treat amphetamine abuse. General value regarding insertion of an NHP model in paradigm rodent-to-human translational research is also suggested.

摘要

急性中枢神经系统暴露于右旋苯丙胺(d-苯丙胺)会引起多种作用,包括对多巴胺转运体(DAT)的双重作用,以增加细胞外多巴胺,并诱导负反馈反应以限制多巴胺的增加。考虑到这些多种作用的半机械性药代动力学和药效学(PK/PD)模型是在此基础上开发的。使用群体方法对 d-苯丙胺在血浆、脑细胞外液(ECF)通过微透析和脑脊液中的综合药代动力学进行了表征。然后,使用通过微透析测量细胞外纹状体多巴胺的间接反应药效学模型,将该 PK 模型与该模型联系起来。在大鼠和非人灵长类动物(NHPs)中,DAT 对多巴胺外流(反向转运)的刺激主要负责多巴胺的剂量线性增加。同样,在这两个物种中,都需要一个调节函数来解释在相对持续的 d-苯丙胺 ECF 暴露下多巴胺反应的丧失,推测是急性耐受反应。PK/PD 模型结构在物种之间是一致的;然而,NHPs 对急性 d-苯丙胺挑战的反应中,多巴胺更快地恢复到基线。这些结果表明,从啮齿动物到 NHPs,关于安非他命增加细胞外多巴胺的机制是一致的,但 NHPs 对这种增加的耐受系统反应更快。这种基于微透析的 PK/PD 模型表明,在指导探索改变反向转运刺激以治疗安非他命滥用的新方法的临床前发现方面具有更大的价值。还建议在啮齿动物到人类的转化研究范式中插入 NHPs 模型具有普遍价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验